Delivery Order SPE2DB25D3110-SPE2DB25FTEFX
- Not listed
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $9,986.44 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This competitively awarded, firm fixed-price contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,577.74. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The award will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a $17,566.90 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a non-set-aside competitive award supporting the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Department of Defense and...
- The Defense Logistics Agency awarded a delivery order valued at $44,935.54 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-line procurement under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $29,266.54 delivery order on August 18, 2025, for Dupixent (dupilumab) 300 mg/2 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $14,369.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. The contract, with an ultimate completion date of July 31, 2025, is a non-set-aside competitive award issued on July 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,709.46 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes. The contract, which is a non-set-aside competitive award with firm fixed pricing, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $14,644.34 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEFXDelivery Order
The Defense Logistics Agency awarded a $7,437.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive, competitively awarded delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical running through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, syringes, and specialized medical supplies across multiple therapeutic domains. The current delivery order for Dupixent, a specialty pharmaceutical used for conditions such as atopic dermatitis and eosinophilic disorders, reflects AmerisourceBergen's ongoing role as a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/2/25 |